344 related articles for article (PubMed ID: 6230083)
41. Antibacterial activity after a single-dose of norfloxacin, ofloxacin and pipemidic acid detected in urine of volunteers.
Cruciani M; Monzillo V; Navarra A; Tinelli C; Concia E
Drugs Exp Clin Res; 1988; 14(8):533-7. PubMed ID: 3150350
[TBL] [Abstract][Full Text] [Related]
42. In vitro antibacterial activity of AM-715, a new nalidixic acid analog.
Ito A; Hirai K; Inoue M; Koga H; Suzue S; Irikura T; Mitsuhashi S
Antimicrob Agents Chemother; 1980 Feb; 17(2):103-8. PubMed ID: 6446258
[TBL] [Abstract][Full Text] [Related]
43. [Structure-activity relationships in the quinolone group: antibacterial activity of two new compounds (author's transl)].
Thibault M; Koumaré B; Soussy CJ; Duval J
Ann Microbiol (Paris); 1981; 132(3):267-81. PubMed ID: 6457546
[TBL] [Abstract][Full Text] [Related]
44. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
Digranes A; Dibb WL; Benonisen E
Chemotherapy; 1985; 31(6):466-71. PubMed ID: 2934234
[TBL] [Abstract][Full Text] [Related]
45. Urine bactericidal activity against resistant Escherichia coli in an in vitro pharmacodynamic model simulating urine concentrations obtained after 2000/125 mg sustained-release co-amoxiclav and 400 mg norfloxacin administration.
Alou L; Aguilar L; Sevillano D; Giménez MJ; Cafini F; Valero E; Relaño MT; Prieto J
J Antimicrob Chemother; 2006 Apr; 57(4):714-9. PubMed ID: 16492718
[TBL] [Abstract][Full Text] [Related]
46. [Comparative in vitro antistaphylococcal effect of norfloxacin and pefloxacin on 312 hospital strains].
Ronco E; Pilliot J
Pathol Biol (Paris); 1985 May; 33(5):381-4. PubMed ID: 3162139
[TBL] [Abstract][Full Text] [Related]
47. [Minimal inhibitory concentration in hospital bacteria].
Marcenac FM; Fernández AJ; Rebollo MN; Helou HT; Civalero TR; Herran IL; Magri MA
Rev Asoc Argent Microbiol; 1974; 6(2):44-61. PubMed ID: 4467221
[No Abstract] [Full Text] [Related]
48. In vitro antibacterial activity of irloxacin (E-3432) on clinical isolates.
Coll R; Esteve M; Moros M; Xicota MA; Parés J
Drugs Exp Clin Res; 1987; 13(2):75-7. PubMed ID: 3582134
[TBL] [Abstract][Full Text] [Related]
49. [A study of the in vitro sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to 7 antimicrobial agents].
Lynch MB; Mimica I; Valenzuela MC; Vilches A; Abarca S
Rev Med Chil; 1972 Jan; 100(1):14-5. PubMed ID: 4622217
[No Abstract] [Full Text] [Related]
50. Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid.
Teoh-Chan CH; Cowlishaw A; Eley A; Slater G; Greenwood D
J Antimicrob Chemother; 1985 Jan; 15(1):45-52. PubMed ID: 3156113
[TBL] [Abstract][Full Text] [Related]
51. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
Leigh DA; Smith EC; Marriner J
J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
[TBL] [Abstract][Full Text] [Related]
52. Experience with ciprofloxacin in vitro and in vivo.
Giamarellou H; Efstratiou A; Tsagarakis J; Petrikkos G; Daikos GK
Arzneimittelforschung; 1984; 34(12):1775-8. PubMed ID: 6442151
[TBL] [Abstract][Full Text] [Related]
53. Antibacterial activity of cinoxacin in vitro.
Giamarellou H; Jackson GG
Antimicrob Agents Chemother; 1975 May; 7(5):688-92. PubMed ID: 1096811
[TBL] [Abstract][Full Text] [Related]
54. In-vitro activity of norfloxacin against Enterobacteriaceae and Pseudomonas aeruginosa.
García-Rodríguez JA; Gómez-García AC; Rodrigo N
J Antimicrob Chemother; 1984 Aug; 14(2):192-3. PubMed ID: 6238928
[No Abstract] [Full Text] [Related]
55. In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.
Downs J; Andriole VT; Ryan JL
Antimicrob Agents Chemother; 1982 Apr; 21(4):670-2. PubMed ID: 6211142
[TBL] [Abstract][Full Text] [Related]
56. Comparative activities of norfloxacin and fifteen other antipseudomonal agents against gentamicin-susceptible and -resistant Pseudomonas aeruginosa strains.
Forward KR; Harding GK; Gray GJ; Urias BA; Ronald AR
Antimicrob Agents Chemother; 1983 Oct; 24(4):602-4. PubMed ID: 6228193
[TBL] [Abstract][Full Text] [Related]
57. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
Cantet P; Renaudin H; Quentin C; Bebear C
Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
[TBL] [Abstract][Full Text] [Related]
58. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
Schröter G; Schrettenbrunner A; Strenzel I
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
[TBL] [Abstract][Full Text] [Related]
59. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
Piccolomini R; Cellini L; Allocati N; Ravagnan G
Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
[TBL] [Abstract][Full Text] [Related]
60. In vitro synergistic activity of some chinolinic compounds combined with beta-lactam antibiotics against gram-positive and gram-negative clinical isolates.
Ravagnan G; Piccolomini R; Speciale AM; Russo G; Renzini G
Chemotherapy; 1985; 31(3):191-9. PubMed ID: 3996087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
